{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:42:50Z","timestamp":1792032170495,"version":"4.4.0"},"reference-count":57,"publisher":"American Society for Microbiology","issue":"5","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2009,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            Antibiotic treatment of\n            <jats:italic>Staphylococcus aureus<\/jats:italic>\n            infections is often problematic due to the slow response to therapy and the high frequency of infection recurrence. The intracellular persistence of staphylococci has been recognized and could offer a good explanation for these treatment difficulties. Knowledge of the interplay between intracellular antibiotic activity and the overall outcome of infection is therefore important. Several intracellular in vitro models have been developed, but few experimental animal models have been published. The mouse peritonitis\/sepsis model was used as the basic in vivo model exploring a quantitative ex vivo extra- and intracellular differentiation assay. The intracellular presence of\n            <jats:italic>S. aureus<\/jats:italic>\n            was documented by electron microscopy. Five antibiotics, dicloxacillin, cefuroxime, gentamicin, azithromycin, and rifampin (rifampicin), were tested in the new in vivo model; and the model was able to distinguish between their extra- and intracellular effects. The intracellular effects of the five antibiotics could be ranked as follows as the mean change in the log\n            <jats:sub>10<\/jats:sub>\n            number of CFU\/ml (\u0394log\n            <jats:sub>10<\/jats:sub>\n            CFU\/ml) between treated and untreated mice after 4 h of treatment: dicloxacillin (3.70 \u0394log\n            <jats:sub>10<\/jats:sub>\n            CFU\/ml) &gt; cefuroxime (3.56 \u0394log\n            <jats:sub>10<\/jats:sub>\n            CFU\/ml) &gt; rifampin (1.86 \u0394log\n            <jats:sub>10<\/jats:sub>\n            CFU\/ml) &gt; gentamicin (0.61 \u0394log\n            <jats:sub>10<\/jats:sub>\n            CFU\/ml) &gt; azithromycin (0.21 \u0394log\n            <jats:sub>10<\/jats:sub>\n            CFU\/ml). We could also show that the important factors during testing of intracellular activity in vivo are the size, number, and frequency of doses; the time of exposure; and the timing between the start of infection and treatment. A poor correlation between the intracellular accumulation of the antibiotics and the actual intracellular effect was found. This stresses the importance of performing experimental studies, like those with the new in vivo model described here, to measure actual intracellular activity instead of making predictions based on cellular pharmacokinetic and MICs.\n          <\/jats:p>","DOI":"10.1128\/aac.01605-07","type":"journal-article","created":{"date-parts":[[2009,2,18]],"date-time":"2009-02-18T09:19:54Z","timestamp":1234948794000},"page":"1874-1883","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":80,"title":["Intracellular Activity of Antibiotics against\n            <i>Staphylococcus aureus<\/i>\n            in a Mouse Peritonitis Model"],"prefix":"10.1128","volume":"53","author":[{"given":"Anne","family":"Sandberg","sequence":"first","affiliation":[{"name":"National Center for Antimicrobials &amp; Infection Control, Statens Serum Institut, 5 Artillerivej, Copenhagen S DK-2300, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas H. R.","family":"Hessler","sequence":"additional","affiliation":[{"name":"National Center for Antimicrobials &amp; Infection Control, Statens Serum Institut, 5 Artillerivej, Copenhagen S DK-2300, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Skov","sequence":"additional","affiliation":[{"name":"National Center for Antimicrobials &amp; Infection Control, Statens Serum Institut, 5 Artillerivej, Copenhagen S DK-2300, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Blom","sequence":"additional","affiliation":[{"name":"Department of Virology, Statens Serum Institut, 5 Artillerivej, Copenhagen S DK-2300, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"Frimodt-M\u00f8ller","sequence":"additional","affiliation":[{"name":"National Center for Antimicrobials &amp; Infection Control, Statens Serum Institut, 5 Artillerivej, Copenhagen S DK-2300, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00402-007-0285-z"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1699-0463.1993.tb00082.x"},{"key":"e_1_3_2_4_2","first-page":"3","volume":"12","year":"2006","unstructured":"Appelbaum, P. C. 2006. MRSA\u2014the tip of the iceberg. Clin. Microbiol. Infect.12(Suppl. 2):3-10.","journal-title":"Clin. Microbiol. Infect."},{"key":"e_1_3_2_5_2","first-page":"16","volume":"12","year":"2006","unstructured":"Appelbaum, P. C. 2006. The emergence of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus. Clin. Microbiol. Infect.12(Suppl. 1):16-23.","journal-title":"Clin. Microbiol. Infect."},{"key":"e_1_3_2_6_2","first-page":"2474","volume":"72","year":"2005","unstructured":"Bamberger, D. M., and S. E. Boyd. 2005. Management of Staphylococcus aureus infections. Am. Fam. Physician72:2474-2481.","journal-title":"Am. Fam. Physician"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.50.3.841-851.2006"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.66.1.336-342.1998"},{"key":"e_1_3_2_9_2","first-page":"251","year":"1978","unstructured":"Brown, K. N., and A. Percival. 1978. Penetration of antimicrobials into tissue culture cells and leucocytes. Scand. J. Infect. Dis. Suppl., p. 251-260.","journal-title":"Scand. J. Infect. Dis. Suppl.,"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-5520(03)00066-7"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.7.2095-2103.2002"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.md.0000091184.93122.09"},{"key":"e_1_3_2_13_2","first-page":"1369","volume":"163","year":"1991","unstructured":"Chuard, C., J. C. Lucet, P. Rohner, M. Herrmann, R. Auckenthaler, F. A. Waldvogel, and D. P. Lew. 1991. Resistance of Staphylococcus aureus recovered from infected foreign body in vivo to killing by antimicrobials. J. Infect. Dis.163:1369-1373.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1136\/pmj.76.898.479"},{"key":"e_1_3_2_15_2","unstructured":"Performance standards for antimicrobial susceptibility Testing; 15th informational supplement (M100-S15). 2008"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.284.5418.1318"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.42.2.377"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1302\/0301-620X.85B6.13509"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.22.5.781"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1012445925628"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2007.02.011"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.276.5313.718"},{"key":"e_1_3_2_23_2","first-page":"127","year":"1999","unstructured":"Frimodt-Moller, N., J. D. Knudsen, and F. Espersen. 1999. The mouse peritonitis\/sepsis model, p. 127-136. In O. Zak and M. A. Sande (ed.), Handbook of animal models of infection. Academic Press, London, United Kingdom.","journal-title":"Handbook of animal models of infection"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe068152"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.164.7.3713"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.54.3.833-836.1986"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-4804(03)00314-7"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1006\/mpat.1995.0075"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.7.2118-2124.2003"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.158.5.509"},{"key":"e_1_3_2_31_2","first-page":"429","volume":"95","year":"1980","unstructured":"Johnson, J. D., W. L. Hand, J. B. Francis, N. King-Thompson, and R. W. Corwin. 1980. Antibiotic uptake by alveolar macrophages. J. Lab. Clin. Med.95:429-439.","journal-title":"J. Lab. Clin. Med."},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1080\/00365540310016682"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.6.1253"},{"key":"e_1_3_2_34_2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.imbio.2007.07.005","volume":"213","year":"2008","unstructured":"Kolaczkowska, E., B. Arnold, and G. Opdenakker. 2008. Gelatinase B\/MMP-9 as an inflammatory marker enzyme in mouse zymosan peritonitis: comparison of phase-specific and cell-specific production by mast cells, macrophages and neutrophils. Immunobiology213:109-124.","journal-title":"Immunobiology"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.40.11.2478"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199808203390806"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0966-842X(00)01803-5"},{"key":"e_1_3_2_38_2","unstructured":"Principles and practice of infectious diseases 2005 vol. 2"},{"key":"e_1_3_2_39_2","unstructured":"Antibiotic and chemotherapy. 1996"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/46.3.429"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-6-49"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/20.1.95"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro1384"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1177\/0091270004273492"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.11.7074-7082.2001"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.31.3.410"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2007.tb01002.x"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01833876"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.159.5.462"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1990.00390180113021"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/21.6.773"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.3.1047-1051.2003"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2958.2003.03618.x"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)05321-1"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01964420"},{"key":"e_1_3_2_56_2","first-page":"218","volume":"9","year":"2006","unstructured":"Van Bambeke, F., M. Barcia-Macay, S. Lemaire, and P. M. Tulkens. 2006. Cellular pharmacodynamics and pharmacokinetics of antibiotics: current views and perspectives. Curr. Opin. Drug Discov. Dev.9:218-230.","journal-title":"Curr. Opin. Drug Discov. Dev."},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.8.2853-2860.2004"},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1994.00420200086009"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01605-07","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01605-07","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T20:22:53Z","timestamp":1645474973000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.01605-07"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":57,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["10.1128\/AAC.01605-07"],"URL":"https:\/\/doi.org\/10.1128\/aac.01605-07","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5]]},"assertion":[{"value":"2007-12-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2009-02-02","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2009-05-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}